Comparison between Dr.Agarwal's Health Care IPO and Stallion India Fluorochemicals IPO.
Dr.Agarwal's Health Care IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Stallion India Fluorochemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dr.Agarwal's Health Care IPO is up to ₹3,027.26 Cr whereas the issue size of the Stallion India Fluorochemicals IPO is up to ₹199.45 Cr. The final issue price of Dr.Agarwal's Health Care IPO is ₹402.00 per share and of Stallion India Fluorochemicals IPO is ₹90.00 per share.
| Dr.Agarwal's Health Care IPO | Stallion India Fluorochemicals IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹382.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹402.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹402.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 35 shares | 165 shares |
| Fresh Issue Size | 74,62,686 shares | 1,78,58,740 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹160.73 Cr |
| OFS Issue Size | 6,78,42,284 shares | 43,02,656 shares |
| OFS Issue Size (Amount) | up to ₹2,727.26 Cr | up to ₹38.72 Cr |
| Issue Size Total | 7,53,04,970 shares | 2,21,61,396 shares |
| Issue Size Total (Amount) | up to ₹3,027.26 Cr | up to ₹199.45 Cr |
Dr.Agarwal's Health Care IPO opens on Jan 29, 2025, while Stallion India Fluorochemicals IPO opens on Jan 16, 2025. The closing date of Dr.Agarwal's Health Care IPO and Stallion India Fluorochemicals IPO is Jan 31, 2025, and Jan 20, 2025, respectively.
| Dr.Agarwal's Health Care IPO | Stallion India Fluorochemicals IPO | |
|---|---|---|
| Anchor Bid Date | Jan 28, 2025 | Jan 15, 2025 |
| Issue Open | Jan 29, 2025 | Jan 16, 2025 |
| Issue Close | Jan 31, 2025 | Jan 20, 2025 |
| Basis Of Allotment (Tentative) | Feb 03, 2025 | Jan 21, 2025 |
| Initiation of Refunds (Tentative) | Feb 04, 2025 | Jan 22, 2025 |
| Credit of Share (Tentative) | Feb 04, 2025 | Jan 22, 2025 |
| Listing date (Tentative) | Feb 04, 2025 | Jan 23, 2025 |
| Anchor Lockin End date 1 | Mar 02, 2025 | Feb 20, 2025 |
| Anchor Lockin End date 2 | May 01, 2025 | Apr 21, 2025 |
Dr.Agarwal's Health Care IPO P/E ratio is 130.44, as compared to Stallion India Fluorochemicals IPO P/E ratio of 37.41.
| Dr.Agarwal's Health Care IPO | Stallion India Fluorochemicals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 37.72 | 94.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 32.5 | 67.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 130.44 | 37.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹12698.37 Cr. | ₹713.93 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.33% | 12.54% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.61% | 13.96% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.08 | ₹2.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 6.21 | 12.54% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dr.Agarwal's Health Care IPO Retail Individual Investors (RII) are offered 2,54,08,599 shares while in Stallion India Fluorochemicals IPO retail investors are offered 2,54,08,599 shares. Qualified Institutional Buyers (QIB) are offered 1,45,19,200 shares in Dr.Agarwal's Health Care IPO and 44,32,279 shares in Stallion India Fluorochemicals IPO.
| Dr.Agarwal's Health Care IPO | Stallion India Fluorochemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,17,78,798 shares | 66,48,418 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,45,19,200 shares | 44,32,279 shares |
| NII | 1,08,89,400 shares | 33,24,210 shares |
| RII | 2,54,08,599 shares | 77,56,489 shares |
| Employee | 15,79,399 shares | 0 shares |
| Others | ||
| Total | 7,53,04,970 shares | 2,21,61,396 shares |
Dr.Agarwal's Health Care IPO subscribed 1.49x in total, whereas Stallion India Fluorochemicals IPO subscribed 188.32x.
| Dr.Agarwal's Health Care IPO | Stallion India Fluorochemicals IPO | |
|---|---|---|
| QIB (times) | 4.41x | 172.93x |
| NII (times) | 0.39x | 422.35x |
| Big NII (times) | 0.29x | 472.89x |
| Small NII (times) | 0.54x | 321.29x |
| RII (times) | 0.42x | 96.81x |
| Employee (times) | 0.26x | |
| Other (times) | 0.51x | |
| Total (times) | 1.49x | 188.32x |
